Hospital Universitario Torrecardenas

At Hospital Universitario Torrecardenas, clinical research in nephrology focuses on focal segmental glomerulosclerosis, IgA nephropathy, idiopathic immune complex mediated membranoproliferative glomerulonephritis, and chronic kidney disease. These studies are mainly designed to test new treatments and measure whether they can slow kidney damage, reduce protein loss, and improve long-term outcomes.

• Testing new therapies for focal segmental glomerulosclerosis and related proteinuric kidney disorders
• Evaluating treatments for IgA nephropathy and other immune-mediated glomerular diseases
• Assessing strategies to slow progression in chronic kidney disease and preserve kidney function

Several of these trials aim to improve daily disease control and support better kidney health over time.

The site also supports studies in cardiovascular disease, including acute myocardial infarction, atherosclerotic cardiovascular disease, and spontaneous coronary artery dissection. The research is centered on preventing major heart events, refining treatment approaches, and understanding which therapies offer the best protection for high-risk patients.

• Preventing recurrent events in acute myocardial infarction and established vascular disease
• Evaluating medical management for spontaneous coronary artery dissection
• Studying therapies that lower cardiovascular risk in people with atherosclerotic cardiovascular disease

These trials reflect a strong interest in improving both immediate care and long-term cardiovascular outcomes.

Research in infectious diseases includes HIV, chronic hepatitis B, chronic hepatitis D, and bacterial bloodstream infections such as Pseudomonas aeruginosa bacteremia and enterococcal bacteremia. The main purpose of these trials is to compare treatment options, improve infection control, and explore approaches that may reduce complications and antibiotic exposure.

• Studying new and existing therapies for HIV and chronic viral hepatitis
• Comparing shorter and longer antibiotic strategies for bacteremia
• Evaluating treatments for resistant bacterial infections and improving infection outcomes

This work highlights the site’s role in both antiviral and antibacterial clinical research.

Clinical trials at Hospital Universitario Torrecardenas also address non-alcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis, obesity, overweight, and type 2 diabetes mellitus. These studies are focused on testing therapies that may improve liver health, reduce fibrosis, and support better metabolic control.

• Evaluating treatments for NASH and MASH with liver fibrosis
• Studying medicines aimed at weight reduction and metabolic improvement
• Assessing whether new therapies can reduce liver injury and related complications

The research combines liver medicine with broader metabolic disease care, reflecting an important area of clinical need.

The site contributes to trials in respiratory disease and immune system disorders, including severe asthma with eosinophilic phenotype and chronic obstructive pulmonary disease. These studies are intended to evaluate how well newer treatments control symptoms, reduce flare-ups, and improve quality of life in patients with difficult-to-manage disease.

• Testing advanced therapies for severe eosinophilic asthma
• Exploring treatment strategies in chronic obstructive pulmonary disease
• Supporting research into better symptom control for chronic airway disease

This area shows a clear focus on improving control of long-standing respiratory conditions.

Within hematology and cancer research, the site studies acute myeloid leukemia, lymphoblastic lymphoma, and locally advanced colon cancer with peritoneal metastases. The main aim is to assess whether new treatment combinations or surgical strategies can improve survival and reduce recurrence.

• Testing new treatment approaches for acute myeloid leukemia
• Evaluating therapy strategies in lymphoblastic lymphoma
• Studying ways to improve outcomes in colon cancer with peritoneal spread

These trials demonstrate active involvement in both blood cancer and solid tumor research.

The research portfolio at the site also includes studies in venous disease, neurology, digestive disorders, and diagnostic and therapeutic techniques. Examples include chronic venous insufficiency, spontaneous lobar intracerebral hemorrhage, fecal incontinence, and type 1 myotonic dystrophy, showing a broad interest in both disease management and innovative care approaches.

• Evaluating therapies for chronic venous insufficiency and venous valve disease
• Studying treatment decisions in intracerebral hemorrhage and related vascular risk
• Exploring regenerative and device-based approaches for fecal incontinence and other complex conditions

These projects add breadth to the site’s clinical research activity and extend beyond its core hematology focus.